Rosopatamab (Anti-FOLH1 / PSMA)

Rosopatamab (Anti-FOLH1 / PSMA) is a humanised monoclonal antibody targeting PSMA. It can be used in cancer research, particularly in prostate cancer. MW: 144.36.
Supplier Selleck Chemicals
Product # A2617
Sku # A2617-1mg
Pricing 1mg, $370.00
Feedback